Roles of estrogens, estrogen-like compounds, and endocrine disruptors in adipocytes.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic search methodology or original empirical data
PubMed 36213285 · doi:10.3389/fendo.2022.921504
What was done
This narrative review summarizes literature on the mechanisms by which estrogens, estrogen receptors (ERα and ERβ), estrogen-like compounds, and endocrine disruptors influence adipocyte differentiation, function, fat distribution, and caloric expenditure, as well as postmenopausal metabolic and cardiovascular risks.
What was found
No quantitative data, sample sizes, or effect estimates are reported in the abstract. The authors state that estrogens promote subcutaneous and extremity adipose distribution while androgens favor visceral and splanchnic accumulation, and that estrogen deficiency during menopause increases predisposition to obesity, diabetes, and cardiovascular disease.
Why it matters
This paper synthesizes molecular and physiological pathways linking sex hormones and endocrine-disrupting chemicals to postmenopausal metabolic alterations and cardiovascular risk.
Limits
The abstract provides no empirical numbers or systematic search methodology. As a narrative synthesis, it cannot quantify effect sizes or establish causality independently of the primary studies it cites.
Cited by
- supports Estrogen directs the body to store fat subcutaneously in adipose tissue rather than viscerally.